Riskpilot← Back to searchSign inGet full accessSaraste terveys Oy
OYActiveY-tunnus 3279750-1Annankatu 16-B49Medical specialists activities · NACE 8622Est. 20221 employees
Revenue 2025
EUR 429K
+66% vs 2024
EBITDA margin
3.2%
-3% vs 2024
Equity ratio
1.4%
Financial strength
Net profit 2025
EUR -3K
-133% vs 2024
| Revenue | EUR 429K | +66% |
| EBITDA | EUR 14K | -3% |
| Net profit | EUR -3K | -133% |
| Total assets | EUR 133K | +63% |
| Equity | EUR 2K | +117% |
| Employees | 1 | — |
Legal name
Saraste terveys Oy
Y-tunnus number
3279750-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
6. huhtikuuta 2022
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on terveyttä ja hyvinvointia edistävien palvelujen tuottaminen. Yhtiö voi tuottaa myös niihin liittyviä muita palveluja kuten koulutusta, konsultointia, tutkimusta sekä tilojen ja työvoiman vuokrausta. Yhtiö voi omistaa ja hallinnoida toimintaa tukevia alustoja kuten tietojärjestelmiä ja ohjelmistoja. Yhtiön voi omistaa arvopapereita ja käydä niillä kauppaa.
Address
Annankatu 16-B49
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 259 | 429 |
| Staff expenses | −21 | −27 |
| EBITDA | 14 | 14 |
| Depreciation & amort. | −2 | −15 |
| EBIT | 12 | −1 |
| Net financials | −3 | −2 |
| Profit before tax | 9 | −3 |
| Tax | −0 | −0 |
| Net profit | 9 | −3 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 81 | 133 |
| Equity | −11 | 2 |
| Long-term debt | 63 | 48 |
| Short-term debt | 29 | 83 |
| Total debt | 92 | 131 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20242025
Equity ratio
1.4%
This company
38.2%
Market median
-96% vs market
20242025
Return on equity
-167.5%
This company
18.4%
Market median
-1010% vs market
20242025
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20242025
Asset turnover
3.23×
This company
1.12×
Market median
+188% vs market
20242025
Debt / equity
70.95×
This company
0.62×
Market median
-11344% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ST Deputy Member | Deputy Member | 2022 |
MS Deputy Member | Deputy Member | 2022 |
KH Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
VA | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Saraste terveys Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Visa Akseli Torvald Kiiski | Audit | 0 companies |
| Sampo Tapio Auro | Deputy Member | 0 companies |
| Matti-Pekka Sävelkoski | Deputy Member | 0 companies |
| Kirsi Hannele Sävelkoski | Chief Executive Officer | 0 companies |
| Kirsi Maria Auro | Chairperson | 0 companies |